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Introduction {#sec1}
============

Terminally differentiated somatic cells can be reprogrammed to become pluripotent either by somatic cell nuclear transfer (SCNT) ([@bib10], [@bib50]) or by the forced expression of reprogramming factors, *Oct4* (O), *Sox2* (S), *Klf4* (K), and *c-Myc* (M) ([@bib44], [@bib45]) to generate induced pluripotent stem cells (iPSCs). Benefits by technical simplification and free of ethical concerns, iPSCs make a significant step forward for patient-specific stem cells and individualized treatment. At the same time, the iPSC generation process is more likely a stochastic event, resulting in very low efficiency (\<1%) while being time-consuming (2--3 weeks) and highly dependent on cell proliferation ([@bib21], [@bib28], [@bib38], [@bib48]). On the other hand SCNT, whereby a somatic nucleus is reprogrammed by oocyte cytosolic factors in a deterministic manner, is rapid, relatively efficient, and cell division independent ([@bib18], [@bib19]). The different efficiency between SCNT and iPSC technology ([@bib24]) implies that some magical factors present in the oocyte might be able to promote iPSC induction. In fact, growing evidence suggests that some oocyte-specific factors can enhance the efficiency and quality of iPSC reprogramming ([@bib7], [@bib15], [@bib17], [@bib22], [@bib23], [@bib33], [@bib41], [@bib42]). However, although many transcription factors have been shown to enhance the generation of iPSCs, the majority of oocyte factors remain poorly investigated.

To investigate the role of oocyte factors in cellular reprogramming, we selected several highly expressed factors in oocytes based on our previously reported mass spectrometry-identified oocyte protein composition pool ([@bib49]) and RNA sequencing (RNA-seq) data ([@bib30]). In the present study, we focused on the maternal factor *Obox1* because it is an extremely poorly studied oocyte-specific factor in development and somatic cell reprogramming. There are eight members in the *Obox* family, six of which were reported to express in germ cells specifically ([@bib37]). *Obox1* was found exclusively expressed in mouse oocytes as early as one-layer follicles and throughout folliculogenesis ([@bib37]). In mouse stem cells, *Obox* genes were negatively regulated by *Lin28* ([@bib35]). CPEB, a sequence-specific RNA binding protein, binds to *Obox1* mRNA and may regulate its polyadenylation-induced translation ([@bib36]). Recently, it was reported that *Setd1b* can promote the expression of the major oocyte transcription factors including *Obox1*, *2*, *5*, and *7* ([@bib2]). However, the function of *Obox1* remains unknown, especially in embryo development and somatic cell reprogramming. Here, we show that the overexpression of *Obox1* can significantly promote the generation of iPSCs together with OSKM and can even replace *Sox2* to achieve pluripotency. Further molecular analysis indicated that the overexpression of *Obox1* can promote mesenchymal-to-epithelial transition (MET) and mitigate cell hyperproliferation, which can in turn selectively increase the proportion of THY1^*−*^ cells dramatically in the early stage of somatic cell reprogramming.

Results {#sec2}
=======

*Obox1* Can Facilitate iPSC Induction {#sec2.1}
-------------------------------------

During the induction of iPSCs from somatic cells using transcription factors, only a very small proportion of cells can be reprogrammed successfully. In contrast, oocyte-based reprogramming is considered more efficient and synchronous. Recently, it has been shown that some oocyte-derived factors can indeed enhance the efficiency and quality of iPSC induction ([@bib8], [@bib17], [@bib22], [@bib23], [@bib33], [@bib41]). We also found several highly expressed factors in oocytes in our previous study ([@bib49]), after which we aimed to illustrate their roles in somatic reprogramming. To this end, we utilized reprogrammable mouse embryonic fibroblasts (MEFs) derived from the transgenic mice carrying the tetO-OSKM transgene and *Oct4*-GFP/*Rosa26*-M2rtTA ([@bib3]). The induced expression of O, S, K, and M under the addition of doxycycline (Dox) was able to reprogram the MEFs into *Oct4*-GFP^+^ iPSCs ([Figure 1](#fig1){ref-type="fig"}A). We found that *Obox1*, *Surf4*, *H1foo*, *Wdr82*, and *Hmg1rs1* can facilitate somatic cell reprogramming to various extent, as judged by *Oct4*-GFP^+^ colony numbers and the percentage of *Oct4*-GFP^+^ cells ([Figures 1](#fig1){ref-type="fig"}B and 1C). Among these factors, *Obox1* exhibited the most dramatic positive effect on iPSC generation. *Obox1* was exclusively expressed in oocytes and early embryos before the 2-cell stage ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Overexpression of *Obox1* accelerated the formation of *Oct4*-GFP^+^ colonies and resulted in a 13-fold increase of *Oct4*-GFP^+^ colony numbers ([Figures 1](#fig1){ref-type="fig"}B and 1D). Notably, the percentage of *Oct4*-GFP^+^ cells also increased up to 10% at day 17 by exogenous *Obox1* along with OSKM ([Figure 1](#fig1){ref-type="fig"}C). The alkaline phosphatase-positive (AP^+^) colonies were also multiplied ([Figure 1](#fig1){ref-type="fig"}E, right panel). The OSKM + *Obox1*-iPSCs exhibited typical embryonic stem cell (ESC) morphology ([Figures 1](#fig1){ref-type="fig"}E \[left and middle panel\], 1F, and [S1](#mmc1){ref-type="supplementary-material"}B) with a compact appearance and a well-defined border and normal karyotype ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Quantitative real-time PCR (qRT-PCR) and immunofluorescence staining indicated that OSKM + *Obox1*-iPSCs exhibited expression of pluripotent genes at the mRNA and protein levels comparable with that of ESCs ([Figures S1](#mmc1){ref-type="supplementary-material"}D and [1](#fig1){ref-type="fig"}G). We then conducted *in vitro* and *in vivo* differentiation assays to examine the differentiation potential of OSKM + *Obox1*-iPSCs ([Figures S1](#mmc1){ref-type="supplementary-material"}E, [1](#fig1){ref-type="fig"}H, and 1I). Through embryoid body (EB)-mediated *in vitro* differentiation, the differentiated cells showed an upregulation of markers of three germ layers ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Teratomas also formed after subcutaneous injection of OSKM + *Obox1*-iPSCs into nude mice, with tissues of three germ layers, including skin epithelium (ectoderm), cartilage (mesoderm), and cuboidal epithelium (endoderm) ([Figure 1](#fig1){ref-type="fig"}H). Furthermore, the chimera formation assay was performed, whereby the OSKM + *Obox1*-iPS cell lines could integrate into the gonads of the chimeric mice ([Figure 1](#fig1){ref-type="fig"}I). *Obox1* is specifically expressed in rodents, and we further investigated whether mouse *Obox1* can promote human iPSC induction, and no positive effects could be observed (data not shown).Figure 1Exogenous Expression of *Obox1* Promotes iPSC Generation(A) Strategy for functional studies of candidate genes in reprogramming. Parallel experiments were performed using individual candidate genes and the empty vector as a control.(B) The number of *Oct4*-GFP^+^ colonies was counted at day 19 after induction.(C) The percentage of *Oct4*-GFP^+^ cells was analyzed by FACS at day 19 after induction.(D) Kinetics of the *Oct4*-GFP^+^ colonies formation are facilitated by *Obox1*.(E) Morphology of *Oct4*-GFP^+^ primary colonies (left and middle panels). Representative AP-stained plates are shown 19 days after induction (right panel). Scale bars, 400 μm.(F) Morphology of OSKM + *Obox1*-iPSC lines. Scale bars, 400 μm.(G) Immunostaining of pluripotent marker genes OCT4 (red), SSEA1 (red), and NANOG (red) in OSKM + *Obox1*-iPSC lines. Nuclear staining by DAPI (blue). Scale bars, 50 μm.(H) H&E staining of teratoma generated from OSKM + *Obox1*-iPSCs showing representative ectodermal (epidermis), mesodermal (cartilage), and endodermal (cuboidal epithelium) tissues. Scale bars, 100 μm.(I) Representative photos of the contribution and spatial distribution of *Oct4*-GFP^+^ cells in the gonads from E12.5 OSKM + *Obox1*-iPSC-derived chimera embryo. Scale bars, 1 mm.Data are presented as the mean ± SEM (n = 3); ^∗^p \< 0.05, ^∗∗^p \< 0.01 by Student\'s t test for comparison and empty vector as control. See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.

*Obox1* Can Replace *Sox2* to Accomplish Successful Somatic Cell Reprogramming {#sec2.2}
------------------------------------------------------------------------------

The drastic enhancement of somatic cell reprogramming by *Obox1* promoted us to further explore whether *Obox1* can replace Yamanaka factors. We then substituted individual factors with *Obox1* and evaluated reprogramming efficiency using the MEFs derived from transgenic mice carrying *Oct4*-GFP/*Rosa26*-M2rtTA (OG2-MEF). Finally, we found that *Obox1* can replace *Sox2* to yield *Oct4*-GFP^+^ colonies with typical ESC colony morphology ([Figures 2](#fig2){ref-type="fig"}A and 2B). The OKM + *Obox1*-iPSCs exhibited typical ESC morphology ([Figure 2](#fig2){ref-type="fig"}C) and positive AP activity ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Besides, they expressed pluripotent markers and cell-surface markers of mouse ESCs ([Figures 2](#fig2){ref-type="fig"}D and 2E). Karyotype analysis showed that OKM + *Obox1*-iPSCs maintained the normal 40 chromosomes ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Moreover, OKM + *Obox1*-iPSCs also exhibited differentiation ability both *in vitro* and *in vivo*. EBs were formed using OKM + *Obox1*-iPSCs, and marker genes of the three germ layers were detected in the plated EBs ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Teratomas with three germ layers could be generated by OKM + *Obox1*-iPSCs ([Figure 2](#fig2){ref-type="fig"}F). Additionally, chimeric mice could be generated by germline transmission ([Figure 2](#fig2){ref-type="fig"}G). To understand the mechanism underlying the substitution, we collected the samples on day 3 of the reprogramming process and performed RNA-seq. Compared with OKM + empty vector, the OSKM and OKM + *Obox1* possessed differential expression genes (DEGs) (fold change \>2) sharing similar pathways by gene ontology (GO) analysis ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E). Thus, oocyte factor *Obox1* not only facilitated iPSC induction, but was also able to replace the Yamanaka factor *Sox2* to accomplish the reprogramming process.Figure 2*Obox1* Can Replace *Sox2* during Somatic Cell Reprogramming(A) The number of *Oct4*-GFP^+^ colonies was counted at the end of induction.(B) Morphology of primary colonies. Scale bars, 400 μm.(C) Morphology of OKM + *Obox1*-iPSC lines. Scale bars, 400 μm.(D) qRT-PCR analysis shows pluripotency gene expression in OKM + *Obox1*-iPSCs. Relative mRNA expression was normalized to hypoxanthine-guanine phosphoribosyltransferase (*Hprt*) mRNA and represented relative to expression in MEFs.(E) Immunostaining of pluripotent markers OCT4 (red), SSEA1 (red), and NANOG (red) in OKM + *Obox1*-iPSC lines. Nuclear staining by DAPI (blue). Scale bars, 50 μm.(F) H&E staining of teratoma generated from OKM + *Obox1*-iPSCs showing representative ectodermal (epidermis), mesodermal (cartilage), and endodermal (cuboidal epithelium) tissues. Scale bars, 100 μm.(G) Representative photos of the contribution and spatial distribution of *Oct4*-GFP^+^ cells in the gonads from E12.5 OKM + *Obox1*-iPSC-derived chimera embryo. Scale bars, 1 mm.Data are presented as the mean ± SEM (n = 3); ^∗∗^p \< 0.01 by Student\'s t test. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

*Obox1* Mitigates Cell Hyper-proliferation and Functions at the Early Stage of Reprogramming {#sec2.3}
--------------------------------------------------------------------------------------------

The positive role of *Obox1* on reprogramming and its ability to replace *Sox2* prompted us to investigate the influence of *Obox1* overexpression on the activation of reprogramming factors and pluripotent genes. Although *Oct4*, *Rex1*, and *Nanog* were expressed remarkably higher under the ectopic expression of *Obox1* in reprogramming compared with the control group ([Figure 3](#fig3){ref-type="fig"}A), overexpression of *Obox1* alone could hardly activate the expression of these genes in MEFs ([Figure 3](#fig3){ref-type="fig"}A). Instead, we noticed that the cell proliferation under *Obox1* overexpression was dramatically different from that of the control. The growth curve during reprogramming showed that the overexpression of *Obox1* resulted in significant reduction of cell proliferation rate as early as the first 2 days ([Figure 3](#fig3){ref-type="fig"}B). Then we analyzed the intermediate population progression at successive time points during reprogramming. Flow cytometry showed that addition of *Obox1* promoted the transition from the THY1^+^ cell population to the THY1^−^ cell population ([Figure 3](#fig3){ref-type="fig"}C), which is accepted as one of the prerequisite characteristics of successful reprogramming in the early stage. Furthermore, SSEA1^+^ and subsequent *Oct4*-GFP^+^ cell numbers were significantly increased by forced expression of *Obox1* ([Figures 3](#fig3){ref-type="fig"}D and [1](#fig1){ref-type="fig"}D). We then investigated the time window during which *Obox1* can enhance somatic cell reprogramming. We introduced *Obox1* at different time points during the somatic cell reprogramming process and examined the number of *Oct4*-GFP^+^ colonies and the percentage of *Oct4*-GFP^+^ cells at the end of reprogramming ([Figures 3](#fig3){ref-type="fig"}E--3G). Early introduction of exogenous *Obox1* before day 4 significantly increased the reprogramming efficiency while *Obox1* overexpression after day 7 showed no obvious effect. These results suggested that *Obox1* plays an important role in promoting somatic cell reprogramming at the initiation phase of reprogramming.Figure 3*Obox1* Mitigates Cell Hyper-proliferation and Functions at the Early Stage of Reprogramming(A) qRT-PCR analysis shows pluripotent gene expression in reprogrammable cells on day 14 post induction with or without *Obox1* or *Obox1*-infected MEFs on day 4, and the empty vector-infected cells as control for each group.(B) Proliferation curves of reprogrammable cells transduced with or without *Obox1*.(C) Kinetic changes of percentage of THY1^+^ population at indicated time points during reprogramming by FACS analysis.(D) Percentage of kinetic changes of percentage of THY1^−^/SSEA1^+^ population during reprogramming by FACS analysis.(E) Strategy of time-course study of *Obox1* during reprogramming.(F) Reprogrammable cells were infected with *Obox1* at indicated time points and the number of *Oct4*-GFP^+^ colonies were counted at 21 days post induction.(G) Reprogrammable cells were infected with *Obox1* at indicated time points and *Oct4*-GFP^+^ cells were analyzed by FACS at 21 days post induction.Data are presented as the mean ± SEM (n = 3); ^∗^p \< 0.05, ^∗∗^p \< 0.01 by Student\'s t test for comparison and empty vector at indicated time points as control.

Genome-wide Analysis of the Effects of *Obox1* Overexpression on Somatic Reprogramming {#sec2.4}
--------------------------------------------------------------------------------------

To understand how *Obox1* promotes the reprogramming process, we employed the reprogrammable system with or without *Obox1* overexpression, and performed RNA-seq and chromatin immunoprecipitation sequencing (ChIP-seq) on day 3. Unsupervised hierarchical clustering analysis ([Figure 4](#fig4){ref-type="fig"}A) and principal component analysis ([Figure S3](#mmc1){ref-type="supplementary-material"}A) based on the RNA-seq data showed high similarity among replicates of the same treatment, while the MEF sample was highly distinguishable from other samples, regardless of whether the exogenous *Obox1* was introduced or not ([Figures 4](#fig4){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}A). Under the overexpression of *Obox1*, the number of DEGs (fold change ≥1.5 and false discovery rate ≤0.05) compared with the MEF was much more than that in the empty vector (control) ([Figure 4](#fig4){ref-type="fig"}B). ChIP-seq exhibited a significantly enriched binding of *Obox1* at promoters ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Moreover, 36.7% of the DEGs had *Obox1* binding within 2 kb of their transcription start sites ([Figure 4](#fig4){ref-type="fig"}C, left column). Most *Obox1* targeted genes were also the targets of *Sox2* by comparing our *Obox1* ChIP-seq dataset and the previously reported *Sox2* ChIP-seq data ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D) ([@bib5]), which provides another explanation for the ability of *Obox1* to replace *Sox2* in reprogramming.Figure 4Genome-wide Analysis of the Effects of *Obox1* Overexpression on Somatic Reprogramming(A) Heatmap shows the Pearson correlation of gene transcription profiles of MEFs, reprogrammable cells transduced with OSKM or OSKM plus *Obox1* on day 3 post induction.(B) Venn diagram shows the overlap of different expression genes between samples (Vector and *Obox1*) on reprogramming day 3 and MEFs. Different expression genes were calculated by EdgeR (see [Experimental Procedures](#sec4){ref-type="sec"}).(C) Different expression genes between samples (Vector and *Obox1*) on reprogramming day 3 were grouped into five clusters by K-means clustering based on RNA-seq data. Heatmap shows different expression genes (red, upregulated genes; blue, downregulated genes), which are targeted by *Obox1* through ChIP-seq (left column). Gene ontology analysis of each cluster is shown in the right column.See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S2](#mmc3){ref-type="supplementary-material"}.

According to the differential expression patterns in the three samples, we obtained several major gene clusters ([Figures 4](#fig4){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}E; [Table S2](#mmc3){ref-type="supplementary-material"}). A large number of genes increased in the early stage of reprogramming were further upregulated by *Obox1* (cluster I; ∼300 genes), and GO analysis showed that they were mainly involved in epithelial cell differentiation and intermediate filament organization. Among these genes, 119 of them possess *Obox1* binding sites. Another impressive cluster (cluster II) was composed of the genes that were significantly increased in the control group compared with MEF, but strikingly decreased under *Obox1* overexpression; around half of them have *Obox1* binding on their promoters, and the pathways associated with the cell cycle and DNA replication were highly enriched in this cluster. There was a similar case in cluster III, where genes had greatly increased control than in the *Obox1* overexpression group, and genes were found to be enriched during M phase and microtubule cytoskeleton organization. Such a retraction in cell division-associated pathways was consistent with the slowdown in cell proliferation rate by *Obox1* overexpression in reprogramming. Those genes (cluster IV, [Figure 4](#fig4){ref-type="fig"}C) that were downregulated early in reprogramming were dramatically decreased under *Obox1* overexpression, including *Thy1* and *Zeb1*, among others. Target analysis by integration of transcriptome and ChIP-seq data with BETA showed that *Obox1* more likely acts as a repressor for these genes ([Figure S3](#mmc1){ref-type="supplementary-material"}F).

*Obox1* Promotes MET in the Initiation Stage of Reprogramming {#sec2.5}
-------------------------------------------------------------

The MET was identified as a hallmark at the initiation phase of MEF reprogramming ([@bib29], [@bib39]). To further explore the role of *Obox1* on MET, we checked the levels of the key epithelial and mesenchymal regulators and fibroblast markers in our RNA-seq dataset. The low expression level of the epithelial genes was found in MEFs and in the empty vector control groups, while *Obox1* overexpression lead to significant upregulation of these genes, including *Cdh1*, *Ocln*, *Epcam*, and *Crb3* ([Figure S4](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc1){ref-type="supplementary-material"}). Consistent with the activation of epithelial-like markers, the expression level of mesenchymal regulators, such as *Snail*, *Slug*, *Zeb1*, and *Zeb2*, were markedly downregulated in the *Obox1* group, and the fibroblast markers *Cdh2* and *Thy1* were also significantly downregulated ([Figure S4](#mmc1){ref-type="supplementary-material"}). These findings suggest that *Obox1* can efficiently stimulate MET at the initiation stage of MEF reprogramming. To confirm this, we examined the RNA expression level of epithelial- and mesenchymal-associated genes during reprogramming by qRT-PCR. As shown in [Figure 5](#fig5){ref-type="fig"}A, concomitant with the Dox induction, the upregulation of epithelial regulators such as *E-cadherin*, *Dsp*, *Crb3*, and *Ocln* can be further elevated by *Obox1* from day 2 to day 6, compared with the control at indicated time points, while the expression level of mesenchymal-associated genes, such as *Twist*, *Zeb1*, and *Zeb2*, were significantly downregulated ([Figure 5](#fig5){ref-type="fig"}B). Western blot analysis further validated the increased expression of E-CADHERIN and CYTOKERATINS ([Figure 5](#fig5){ref-type="fig"}C). Prominent *Obox1* peaks in the promoter regions of epithelial-associated regulators *Dsp*, *Crb3*, and *Irf6* suggested direct binding and regulation ([Figure 5](#fig5){ref-type="fig"}D). Therefore, *Obox1* significantly promotes MET, which may in turn contribute to its role in enhancing somatic cell reprogramming.Figure 5*Obox1* Promotes MET at the Initiation Stage of Reprogramming(A) qRT-PCR analysis of epithelial genes expression in *Obox1*-infected reprogrammable cells at indicated time points. The expression levels were normalized to *Hprt*.(B) qRT-PCR analysis of mesenchymal genes expression in *Obox1*-infected reprogrammable cells at indicated time points. The expression levels were normalized to *Hprt*.(C) Western blot analysis the protein levels of E-CADHERIN and Pan-CYTOKERATIN during reprogramming; α-TUBULIN was used as a loading control (V, vector; O, *Obox1*).(D) ChIP density profiles of *Obox1* at epithelial-related gene promoters.Data are presented as the mean ± SEM (n = 3); ^∗^p \< 0.05, ^∗∗^p \< 0.01 by Student\'s t test for comparison and empty vector at indicated time points as control. See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc1){ref-type="supplementary-material"}.

*Obox1* Mitigates Cell Hyper-proliferation by Modulating Cell-Cycle-Related Gene Expression {#sec2.6}
-------------------------------------------------------------------------------------------

As mentioned above, OSKM reprogramming cells displayed a much higher proliferation rate compared with that of OSKM + *Obox1* reprogramming cells ([Figure 3](#fig3){ref-type="fig"}B). Transcriptome profile showed that the genes associated with cell-cycle regulation remained unchanged or downregulated in the *Obox1* group while these genes were markedly upregulated in the control group ([Figure 4](#fig4){ref-type="fig"}C). As shown in [Figure S5](#mmc1){ref-type="supplementary-material"}A, the cyclin-dependent kinases (CDKs), cell division cycle proteins, and other cell-cycle-related genes were dramatically upregulated in OSKM reprogramming cells compared with those of OSKM + *Obox1* reprogramming cells ([Figure S5](#mmc1){ref-type="supplementary-material"}A and [Table S4](#mmc1){ref-type="supplementary-material"}). Next, we performed qRT-PCR to validate expression levels of the genes associated with the cell cycle during reprogramming ([Figure 6](#fig6){ref-type="fig"}A). In addition, ChIP-seq analysis showed that *Obox1* was enriched at the promoter regions of these genes, indicating direct regulation of the cell cycle by *Obox1* ([Figure S5](#mmc1){ref-type="supplementary-material"}B). More interestingly, overexpression of *Obox1* alone does not affect cell number ([Figure 6](#fig6){ref-type="fig"}B), which suggests that the slowdown in cell proliferation rate by *Obox1* might depend on OSKM expression. Furthermore, the impact of *Obox1* on cell proliferation during reprogramming was also reflected in the cell-cycle properties. Distinct cell-cycle stage composition is reconstructed at the initial phase in OSKM-mediated reprogramming. Hoechst 33342 DNA staining assay and bromodeoxyuridine (BrdU) incorporation assay showed a markedly shortened G~1~ phase in OSKM reprogramming cells while this shortened G~1~ was not obvious in *Obox1* + OSKM reprogramming cells ([Figures 6](#fig6){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}C).Figure 6*Obox1* Mitigates Cell Hyper-proliferation and Enlarges the Proportion of THY1^−^ Cells during Reprogramming(A) qRT-PCR analysis of cell-cycle-related gene expression in reprogrammable cells transduced with OSKM or OSKM plus *Obox1* on day 2 post induction. The expression level was normalized to *Hprt*.(B) Proliferation curves of MEFs transduced with or without *Obox1* or OSKM, respectively (empty vector as control).(C) Cell-cycle analysis by FACS in MEFs or the reprogramming cells on day 2 post infection and comparison of the indicated cell-cycle phase (empty vector versus MEF; Obox1 versus empty vector).(D) Proliferation curve of THY1^+^ and THY1^−^ cells sorted from reprogrammable cells on day 2 post induction. The cells were seeded in 24-well plates at a density of 1.2 × 10^4^ cells per well and counted at indicated time points, and the THY1^+^ population and THY1^−^ population compared in the same group.(E) qRT-PCR analysis of cell-cycle-related gene expression in THY1^+^ and THY1^−^ cell populations sorted from reprogrammable cells on day 2 post induction. The expression levels were normalized to *Hprt*. THY1^+^ in vector or *Obox1* group as control.Data are presented as the mean ± SEM (n = 3); ^∗^p \< 0.05, ^∗∗^p \< 0.01 by Student\'s t test for comparison. See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Table S4](#mmc1){ref-type="supplementary-material"}.

Since *Obox1* accelerated the reduction in the THY1^+^ cell population ([Figure 3](#fig3){ref-type="fig"}C), we next asked whether *Obox1* has a different effect on THY1^+^ and THY1^−^ cell growth. After Dox induction for 2 days, we sorted the THY1^+^ and THY1^−^ cells and performed a cell proliferation assay. Consistent with previous studies, OSKM induced a strong increase of cell proliferation rate in both the THY1^+^ and THY1^−^ cell populations during reprogramming ([Figure 6](#fig6){ref-type="fig"}D). As shown in [Figure 6](#fig6){ref-type="fig"}D, in the OSKM + *Obox1* group THY1^−^ cells displayed increased proliferation similarly to OSKM-induced reprogramming, whereas the growth of THY1^+^ cells was dramatically reduced and eventually ceased. This result was consistent with the expression features of cell-cycle-related genes. Most cell-cycle-related genes were downregulated by *Obox1* in both THY1^+^ and THY1^−^ populations, but seemed much more obvious in the THY1^+^ population ([Figure 6](#fig6){ref-type="fig"}E).

Taken together, our data suggested that *Obox1* can modulate the expression of genes associated with the cell cycle and that a proportion of THY1^−^ cells shows selective growth advantage over THY1^+^ cells.

Discussion {#sec3}
==========

Our study aims to discover more native oocyte-derived factors that can facilitate somatic cell reprogramming ([@bib11]). By performing small-scale screening, we demonstrated that the oocyte factor *Obox1* can markedly facilitate iPSC induction together with OSKM and can even replace *Sox2* to accomplish somatic cell reprogramming. Furthermore, we found that overexpression of *Obox1* during reprogramming can promote MET and mitigate cell hyper-proliferation, which can in turn increase the proportion of THY1^−^ cells dramatically, thus benefiting the reprogramming efficiency.

As reported previously, MET is one of the critical early events in reprogramming of MEFs into iPSCs ([@bib29], [@bib39]). As our ChIP-seq and RNA-seq analyses of OSKM + *Obox1* in the reprogramming showed, *Obox1* upregulated the epithelial-associated genes such as *Dsp* and *Crb3*, as well as *Smad7*, which is a key repressor of transforming growth factor β (TGF-β) signaling. TGF-β is a strong signal for EMT and the inhibition of this pathway (by small-molecule compounds or *Smad7* overexpression) have been proved able to enhance reprogramming and replace c-*Myc* and *Sox2* ([@bib16], [@bib29], [@bib34]). Targeting *Smad7* and the epithelial factors and subsequently promoting MET in early reprogramming by overexpression of *Obox1* may be the explanation for its ability to replace the role of *Sox2* to achieve reprogramming together with OKM.

Cell proliferation is another important characteristic in reprogramming. While some factors advanced the iPSC derivation by increased cell growth, others facilitated the reprogramming independent of proliferation ([@bib12]). Until now, the role of cell proliferation on reprogramming has remained controversial. It is reported that rapid proliferation facilitates reprogramming ([@bib14], [@bib21], [@bib38]), but excessive proliferation also decreased the reprogramming efficiency of both mouse and human fibroblasts ([@bib9], [@bib51]), while inhibition of cell proliferation by chemotherapeutic drugs at an early reprogramming stage could help to improve efficiency ([@bib51]). In our study an appropriate dose of ectopic *Obox1* negatively regulated cell proliferation, including downregulating cyclins, CDKs, and the genes involved in DNA replication, chromatin condensation, and cytokinesis, and upregulating cyclin-dependent kinase inhibitors. Moreover, the effect of *Obox1* was shown to be much greater on the hyper-proliferation of THY1^+^ cells, leading to an increased proportion of THY1^−^ cells thus able to facilitate the reprogramming process.

It is predicted that *Obox1* may function as a repressor rather than an activator ([Figure S3](#mmc1){ref-type="supplementary-material"}F). This could be due to its homeodomain-related and helix-turn-helix motif, lambda-like repressor domains ([@bib6]). Although *Obox1* and *Obox2* share 97% similarity (only six different amino acid residues are different), their effects on reprogramming efficiency were different ([Figures 1](#fig1){ref-type="fig"}B and 1C). The individual characteristics of the side chain lead to the different elaborate three-dimensional structure between *Obox1* and *Obox2*, which endows them with unique functions. For instance, the amino acid Leu76 in *Obox1*, located near the first helix, may fold in a hydrophobic pocket together with other amino acids, while Pro76 in *Obox2* may cause a turn and change the direction of the main chain of the protein ([@bib13], [@bib31], [@bib40]).

*Obox1* is an oocyte-specific protein first induced in early follicle growth that maintains high expression in oocytes and early embryo until the 2-cell stage ([@bib6], [@bib37]), which is also supported by our study. *Obox1* belongs to the *Obox* family, which possesses the conserved homeodomain (and hence potential transcription factors) preferentially expressed in germ cells ([@bib37]). Knockdown of *Obox4* in oocytes resulted in abnormal metaphase I arrest via STAT3 and MPF/MAPK signaling pathways ([@bib25], [@bib26]). *Obox6* knockout mice undergo normal early embryonic development and are fertile ([@bib4]). The functional study of *Obox1* is thus far blank. The reduction of cell proliferation rate by *Obox1* in somatic cell reprogramming mimics the early embryo state to some extent. In fact, nearly half of the DEGs specifically upregulated by *Obox1* (288/620) in our data are also highly expressed in zygote/2-cell embryo ([@bib32]). Taken together, this evidence suggests that *Obox1* is an extremely important factor in embryo development and reprogramming, and the functional exploration of its role during the folliculogenesis, oogenesis, and early embryo development would be very helpful in unveiling the mysterious oocyte factors and reprogramming process.

Experimental Procedures {#sec4}
=======================

Candidate Genes' Lentiviral Vector Construction and iPSC Derivation {#sec4.1}
-------------------------------------------------------------------

Full-length mouse *Acot7* (NM_001146057, NM_133348), *Dnm1l* (NM_152816.3), *H1foo* (NM_138311), *Hmga1-rs1* (NM_001166476), *Polr2d* (NM_027002, NM_027101), *Surf4* (NM_011512), *Wdr82* (NM_029896), *Obox1* or FLAG-tagged-*Obox1* (NM_027802), and *Obox2* (NM_145708, AF461107) were cloned and inserted into the FUW-TET-On vector. Inducible iPSCs were generated as previously described ([@bib1], [@bib43]). ESC-like colonies appeared 2--3 weeks after induction. The colonies were picked and propagated after Dox withdrawal.

The analyses of iPSCs, such as qRT-PCR, AP staining, *in vitro* differentiation, teratoma formation, and chimera experiments, were performed as previously described ([@bib20]), as detailed in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. All primer sequences are available in [Table S1](#mmc2){ref-type="supplementary-material"}.

RNA Sequencing {#sec4.2}
--------------

Total RNA from independent biological replicates of each uninduced MEF, induced MEFs with or without *Obox1* at 72 hr for OSKM + *Obox1* system, and of overexpressing OSKM, OKM + *Obox1*, or OKM + empty vector at 72 hr for replacement system, was isolated using the QIAGEN RNeasy Kit (Germantown, USA). The RNA samples were subject to mRNA fragmentation, cDNA synthesis, and library preparation using a KAPA Stranded RNA-Seq Kit Illumina platform (KK8440; Kapa, Wilmington, USA). All adapters were diluted from the adapters offered by TruSeq Library Prep Pooling kit (Illumina, USA). Single-end 50-bp sequencing was further performed on HiSeq 2500 (Illumina) at Berry Genomics.

ChIP Sequencing {#sec4.3}
---------------

ChIP experiments were performed using the MAGnify Chromatin Immunoprecipitation System (Invitrogen, Carlsbad, USA) according to the manufacturer\'s recommendations. Ten million cells on reprogramming day 3 were used for per immunoprecipitation reaction. In brief, cells were chemically crosslinked at room temperature by the addition of formaldehyde to 1% final concentration for 10 min and quenched with 0.125 M final concentration glycine. Crosslinked cells were resuspended in lysis buffer and chromatin was sonicated to 100--400 bp with a Covaris M220 system. The sonicated chromatin was then immunoprecipitated with 3 μg of FLAG antibody (Sigma F1804; St. Louis, USA) for each immunoprecipitation reaction. A fraction of "whole-cell extract" obtained without antibody was retained as an input control. DNA was eluted by elution buffer and purified through phenol-chloroform extraction and isopropanol precipitation. The sequence libraries were generated using a KAPA HyperPlus Library Preparation kit (KK8510; Kapa), following the manufacturer\'s instructions. Single-end 50-bp sequencing was further performed on a HiSeq 2500 (Illumina) at Berry Genomics.

Trimming and Alignment of Sequencing Reads {#sec4.4}
------------------------------------------

All of the RNA-seq reads were first mapped to hg19 reference genome using TopHat (v 2.1.1) with default parameters ([@bib46]). Gene expression for each sample was quantified to FPKM (fragments per kilobase of transcript per million mapped reads) using Cufflinks (v 2.2.1) to eliminate the effects of sequencing depth and transcript length ([@bib47]). All ChIP-seq samples were mapped to mm9 reference genome using the bowtie 2 (v 2.2.9) command with default parameters ([@bib27]).

Cell Growth Curve, BrdU Assay, and Cell-Cycle Analysis {#sec4.5}
------------------------------------------------------

For growth curve analysis, the cells were plated onto 12-well plates at a density of 1.2 × 10^4^ cells per well, and were harvested every 48 or 72 hr and counted in a cell-counting chamber. Each group contained two or three replicates. For BrdU incorporation assay, cells were treated with BrdU for 60 min. The cells were stained following the manufacturer\'s instructions (FITC BrdU Flow Kit, Becton Dickinson, San Jose, USA). For cell-cycle analysis, cells were stained with Hoechst 33342 (Sigma) and analyzed using a Beckmam Coulter CytoFLEX S flow cytometer or BD FACSAria II (for sorting).

Mice {#sec4.6}
----

All of our study procedures were consistent with those in the Tongji University guide for the care and use of laboratory animals.

Statistical Analysis {#sec4.7}
--------------------

Results are presented as the mean ± SEM of independent experiments. Significance was determined by Student\'s t test.
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Accession Numbers {#app1}
=================

The sequencing datasets have been deposited in NCBI\'s Gene Expression Omnibus and are accessible through the accession number GEO: [GSE97859](ncbi-geo:GSE97859){#intref0010}.
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Document S1. Supplemental Experimental Procedures, Figures S1--S5, and Tables S3 and S4Table S1. Primer Sequences Used in this Paper, Related to Figure 1Table S2. Different Expression Genes with or without *Obox1* on Reprogramming Day 3, Related to Figure 4Different expression genes between samples (Vector and *Obox1*) on reprogramming day 3 were grouped into five clusters by K-means clustering based on RNA-seq data. The potential targets of *Obox1* based on the ChIP-seq data are presented as 1 in the binding column.Document S2. Article plus Supplemental Information
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